ESCRS - PP21.18 - Effect Of 0.09% Topical Bromfenac In Managing First Day Discomfort Following Photorefractive Keratectomy Compared To Our Up-Till-Now, Standard Technique

Effect Of 0.09% Topical Bromfenac In Managing First Day Discomfort Following Photorefractive Keratectomy Compared To Our Up-Till-Now, Standard Technique

Published 2022 - 40th Congress of the ESCRS

Reference: PP21.18 | Type: Free paper | DOI: 10.82333/bdtm-z065